Anna Goussia
Overview
Explore the profile of Anna Goussia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liontos M, Goussia A, Korfiatis N, Papadopoulou K, Kanellis G, Visvikis A, et al.
Clin Genitourin Cancer
. 2024 Nov;
23(1):102253.
PMID: 39577124
Background: Cabazitaxel is an effective treatment in metastatic castration-resistant prostate cancer (mCRPC) patients previously exposed to docetaxel and novel hormonal treatments. Understanding the molecular biology of mCRPC disease and taking...
2.
Nikolaidi A, Papadopoulou E, Haidopoulos D, Liontos M, Fountzilas E, Tsaousis G, et al.
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518021
Background: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) and adjuvant chemotherapy is a therapeutic choice for women with advanced ovarian cancer. Whether NACT affects the tumor's molecular profile...
3.
Baltagiannis E, Tsili A, Goussia A, Glantzouni A, Frigkas K, Charchanti A, et al.
Ann Gastroenterol
. 2024 May;
37(3):255-265.
PMID: 38779639
Cystic liver disease has been increasingly reported in the literature, with a prevalence as high as 15-18%. Hepatic cysts are usually discovered incidentally, while their characterization and classification rely on...
4.
Dimitrakopoulos F, Goussia A, Koliou G, Dadouli K, Batistatou A, Kourea H, et al.
Breast
. 2024 Jan;
73:103668.
PMID: 38176305
Background: Dose-dense sequential (dds) chemotherapy has changed the clinical outcome of patients with early breast cancer (BC). To investigate the impact of dose intensity (DI) in the adjuvant setting of...
5.
Fountzilas E, Kouspou M, Eliades A, Papadopoulou K, Bournakis E, Goussia A, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511593
The data on tumor molecular profiling of European patients with prostate cancer is limited. Our aim was to evaluate the prevalence and prognostic and predictive values of gene alterations in...
6.
Dimas A, Goussia A, Papoudou-Bai A, Politi A, Paschopoulos M, Navrozoglou I, et al.
Clin Transl Oncol
. 2023 Jun;
26(1):260-268.
PMID: 37382757
Objectives: To examine the relation of corticotropin-releasing hormone (CRH) family peptides with inflammatory processes and oncogenesis, emphasizing in vulvar inflammatory, premalignant and malignant lesions, as well as to investigate the...
7.
Mantelou A, Barbouti A, Goussia A, Zacharioudaki A, Papoudou-Bai A, Vlachou C, et al.
Free Radic Biol Med
. 2022 Oct;
193(Pt 1):227-237.
PMID: 36243210
Background: The underlying pathophysiological mechanisms of hepatic ischemia-reperfusion (I/R) injury have not been completely elucidated. However, it is well known that oxidative stress, caused by a burst of reactive oxygen...
8.
Papadopoulou K, Koliou G, Tsimiliotis D, Kotoula V, Foukas P, Goussia A, et al.
Urol Oncol
. 2022 Aug;
40(12):538.e15-538.e24.
PMID: 36041976
Background: Bladder cancer (BC) is a heterogeneous malignancy with dismal outcome. Patients And Methods: Mutations in genes, altered or linked to platinum sensitivity in BC, were examined in 66 patients'...
9.
Pappas-Gogos G, Tepelenis K, Goussia A, Tellis C, Fousekis F, Glantzounis G, et al.
Front Oncol
. 2022 Jun;
12:905168.
PMID: 35712481
Intestinal metaplasia of the stomach (IM) is considered a pre-cancerous lesion and is a potential precursor to adenocarcinoma. Metabolic syndrome (MetS) has been associated with lesions to the gastrointestinal tract...
10.
Kyrochristos I, Glantzounis G, Goussia A, Eliades A, Achilleos A, Tsangaras K, et al.
Front Oncol
. 2022 Apr;
12:855463.
PMID: 35402285
Introduction: The mechanisms underlying high drug resistance and relapse rates after multi-modal treatment in patients with colorectal cancer (CRC) and liver metastasis (LM) remain poorly understood. Objective: We evaluate the...